Physician

Mark Oertel, MD

According to 2025 Medicare claims, Mark Oertel, MD (NPI: 1861703860) practices endocrinology in the Lawrence, KS market, with the plurality of this provider's patient population coming from Douglas, KS. This provider's primary affiliated billing organization is LAWRENCE PHYSICIANS LLC (NPI: 1548677792; TIN: 471216616) and primary practice location at 66044-1328.

Oertel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 640 traditional Medicare patients, billed 6,328 HCPCS/CPT codes, and received $128,886 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,829 prescription claims across 548 beneficiaries totaling $1,382,616 in drug costs, led by Ozempic (Semaglutide). DME data shows 812 claims. Open Payments data shows 19 records totaling $423. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,305 to $128,886. Similarly, Part D prescription costs have risen steadily, from $34,521 to $1,382,616. For DME billing, reported payments moved sharply higher in recent years, from $1,285 to $216,316.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	29	50	$2,305
2016	187	380	$19,384
2017	325	995	$43,595
2018	307	1,057	$45,254
2019	328	1,109	$50,360
2020	331	979	$48,695
2021	428	1,228	$76,967
2022	502	4,466	$102,879
2023	587	5,405	$121,347
2024	640	6,328	$128,886

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	46	650	$34,521
2016	162	807	$190,312
2017	238	2,408	$800,044
2018	268	2,791	$963,135
2019	299	2,937	$1,151,572
2020	330	3,222	$1,379,985
2021	407	3,553	$1,685,022
2022	455	3,162	$1,327,078
2023	510	3,420	$1,521,529
2024	548	3,829	$1,382,616

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	15	$291
2016	27	53	$779
2017	107	379	$31,676
2018	150	527	$59,327
2019	216	739	$121,036
2020	250	916	$160,200
2021	269	1,158	$228,406
2022	250	1,175	$226,617
2023	282	1,329	$276,717
2024	230	812	$245,142

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	184	252	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	267	323	$83
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	153	225	$24
83036	Hemoglobin a1c level	235	328	$9
36415	Insertion of needle into vein for collection of blood sample	132	148	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	314	12,088	$381,845
Mounjaro	Tirzepatide	179	5,516	$199,043
Jardiance	Empagliflozin	137	6,248	$119,790
Tresiba Flextouch U-100	Insulin Degludec	143	8,493	$85,091
Tresiba Flextouch U-200	Insulin Degludec	69	3,528	$73,500

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	84	371	$162,108
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	23	90	$30,766
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	29	81	$19,572
E0784	External ambulatory infusion pump, insulin	Y	11	57	$18,501
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	27	78	$6,577

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$423	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Oertel, MD?

Tedicare shows public-source Medicare data for Mark Oertel, MD (NPI 1861703860), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Oertel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Oertel, MD?

Mark Oertel, MD is linked to LAWRENCE PHYSICIANS LLC (billing NPI 1548677792) in the available physician profile data.

Does Mark Oertel, MD have Open Payments data?

Mark Oertel, MD has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.